Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Agent and Profiling Utilization Registry (TAPUR) Study

NCT02693535 is registered in ClinicalTrials.gov with American Society of Clinical Oncology as lead sponsor.

NCT NCT02693535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02693535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Lead sponsor
American Society of Clinical Oncology
Phase
Phase 2
Overall status
Recruiting
Start date
March 14, 2016
Completion date
December 31, 2028
Enrollment
4,200 (estimated)
Sites
181

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, lymphoma, non-hodgkin, multiple myeloma